- Autism
- Birth Defects
- Blindness: Fungal Keratitis
- Blindness: NAION
- Breast Cancer
- Cardiovascular: Drug-Induced Hypertension, Heart Attack
- Depression: Drug-Induced with Possible Thoughts of Suicide
- Diabetes
- Gastrointestinal: Esophagitis
- Gastrointestinal: Irritable Bowel Syndrome (IBS) / Inflammable Bowel Disease (IBD)
- Kidney Damage / Renal Failure
- Liver Damage: Drug-Induced or Toxic Hepatitis
- Lupus
- NSF / NFD (Nephrogenic Fibrosing Dermopathy)
- Osteonecrosis / Dead Jaw
- Stevens Johnson Syndrome / Toxic Epidermal Necrolysis Syndrome (TEN) or Lyell's Syndrome
- Stroke / Blood Clots
HOME | BLOG | CONTACT US
Diseases & Conditions Blog
FDA Recommends Medical Device User Fee Program - Monday, September 17, 2007
The FDA has proposed a recommendation to Congress for reauthorizing the Medical Device User Fee and Modernization ACT (MDUFMA), which would help to ensure that safe and effective medical devices get to patients in a timely fashion. Under this program, industry covers a portion of the costs of the FDA's pre-market review program through a variety of fees. The additional revenues generated from the fees paid by the medical device industry would continue to be used to ensure patients have timely access to safe and effective medical devices.
This proposal, if adopted, would foster the development of innovative in vitro diagnostic tests by issuing new industry guidance on emerging issues and reviewing some low-risk devices to determine whether any of them could be exempted from the need for product review.
0 Comments:
Post a Comment
<< Back